Gynecor™, a Division of Bostwick Laboratories, Adds New State-of-the-Art Lab Technology to Help Physicians Identify Patients at Risk for Cervical Cancer, Improve Treatment Decisions

Published: Sep 26, 2012

ORLANDO, Fla.--(BUSINESS WIRE)--Gynecor, a division of Bostwick Laboratories, Inc. an anatomical pathology and molecular testing laboratory, has made an investment in advanced laboratory technology to help physicians know more about a patient’s condition and to help them identify which patients are at risk for certain diseases, such as cervical cancer, to help improve patient treatment decisions.

Back to news